Status:

COMPLETED

Subclinical Atherosclerosis in HIV-infected Patients

Lead Sponsor:

Massachusetts General Hospital

Collaborating Sponsors:

Bristol-Myers Squibb

Conditions:

HIV Infections

Coronary Atherosclerosis

Eligibility:

All Genders

18-60 years

Brief Summary

We will obtain data using multi-slice CT technology to detect subclinical coronary disease in the HIV population. Determination of subclinical cardiovascular disease using noninvasive technology and e...

Eligibility Criteria

Inclusion

  • Inclusion criteria for HIV infected subjects arm:
  • Men and women age 18-60
  • BMI 20-35
  • Previously documented HIV disease for 5 years or longer either on stable highly active anti-retroviral therapy (HAART) or not on HAART.
  • No changes in antiretroviral regimen within the prior 3 months.
  • Inclusion criteria for non-HIV infected control subjects arm:
  • Healthy men and women age 18-60
  • BMI 20-35
  • Exclusion criteria for both arms:
  • Previously diagnosed coronary artery disease, cerebrovascular disease, or peripheral vascular disease.
  • Use of glucocorticoids, growth hormone, testosterone, or other anabolic agents within past 6 months
  • Renal disease or creatinine \>1.5 mg/dL
  • Anti-inflammatory medications
  • Opportunistic infection within past 6 months in HIV infected individuals and current acute infectious illness in both HIV-infected subjects and normal controls.
  • Nitrates or others medications that can alter endothelial function
  • Contraindication to beta-blocker use
  • Body weight greater than 300 lbs due to DEXA scanner table limitations
  • Patients with previous allergic reactions to iodine-containing contrast media or to iodine will be excluded from participation
  • Active illicit drug use
  • Pregnancy or breastfeeding
  • Estrogen or progestin use

Exclusion

    Key Trial Info

    Start Date :

    June 1 2006

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    February 1 2013

    Estimated Enrollment :

    263 Patients enrolled

    Trial Details

    Trial ID

    NCT00455793

    Start Date

    June 1 2006

    End Date

    February 1 2013

    Last Update

    December 2 2013

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Massachusetts General Hospital

    Boston, Massachusetts, United States, 02114